|
| |
OpportunisticDownload PDF containing detailed information.
Recent Publications on Opportunistic: |  |
Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome.
OBJECTIVE:: To evaluate the International Network for the Study of... | 21st November, 2009
| aDivision of Immunology, Infection and Inflammatory Disease, King's
| AIDS. 2009 Nov 18.
DOI Direct Link |
The Pseudomonas aeruginosa oxidative stress regulator OxyR influences pyocyanin and rhamnolipids production: protective role of pyocyanin.
The LysR-type transcriptional regulator (LTTR) OxyR orchestrates the... | 21st November, 2009
| Vrije Universiteit Brussel.
| Microbiology. 2009 Nov 19.
DOI Direct Link |
Genotyping of Mycobacterium avium complex organisms using Multispacer Sequence Typing.
Mycobacterium avium complex (MAC) comprises several species of... | 21st November, 2009
| Universite de la Mediterannee, Marseille, France;
| Microbiology. 2009 Nov 19.
DOI Direct Link |
Beverages obtained from soda fountain machines in the U.S. contain microorganisms, including coliform bacteria.
Ninety beverages of three types (sugar sodas, diet sodas and water) were... | 21st November, 2009
| Department of Biology, Virginia Western Community College, Roanoke, VA,
| Int J Food Microbiol. 2009 Nov 6.
DOI Direct Link |
Characterization of the L-Lactate Dehydrogenase from Aggregatibacter actinomycetemcomitans.
Aggregatibacter actinomycetemcomitans is a Gram-negative opportunistic... | 20th November, 2009
| Section of Molecular Genetics and Microbiology, The University of Texas at
| PLoS One. 2009 Nov 17;4(11):e7864.
DOI Direct Link |
→View more research publications. |
Press Releases About Opportunistic:
|
 |
| Oral Cancer Foundation to Donate Screening Devices to Free Clinics |
5th October, 2009 |
The Oral Cancer Foundation |
Phoenix's Native American Community Health Center Is First Recipient of adjunctive screening system
NEWPORT BEACH, Calif., Oct. 5 /PRNewswire-USNewswire/ -- The Oral Cancer Foundation recently
|
| ImQuest Presentations at CROI Report Significant Advances in Therapeutic and Microbicide Product Development Programs |
20th February, 2009 |
ImQuest Life Sciences, Inc. |
FREDERICK, Md., Feb. 20 /PRNewswire/ -- ImQuest Life Sciences presented important new results on the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the 16th
|
| Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients |
26th October, 2008 |
Schering-Plough Corporation |
Data Analysis of Up to Four Years of Treatment Presented at ICAAC/IDSA 2008 Annual Meeting
WASHINGTON, Oct. 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported a data
|
| VIRxSYS to Host a Web Conference to Announce Clinical Trial Update |
21st July, 2008 |
VIRxSYS Corporation |
GAITHERSBURG, Md., July 21 /PRNewswire/ -- VIRxSYS Corporation, a
privately held company developing gene therapies for HIV and genetic diseases,
will present an update on the VRX496 Phase I and
|
| Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay |
5th June, 2008 |
Monogram Biosciences, Inc. |
SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc. (Nasdaq: MGRM) today announced immediate availability of
enhanced sensitivity in its Trofile assay. Trofile
|
Companies working in the area of Opportunistic from Bioportfolio's Biocorporate database : | |
| Company Name | |
Amarin Corporation is a specialty pharmaceutical company focused on pain management and neurology.
Amarin is following three specific strategies:
Deriving sales growth from its...
www.amarincorp.com/ View full profile
| |
Immtech International is a biopharmaceutical company focusing on the discovery and development of therapeutic products for the treatment of opportunistic diseases and cancer in patients with...
www.immtech-international.com/ View full profile
| |
Mitotix is a privately held company focused on the discovery and development of therapeutic products for the treatment of diseases resulting from inappropriate cell proliferation. The Company's...
www.mitotix.com/ View full profile
| | →View more Opportunistic related companies. |
BioPortfolio Ltd. offers e-mail and postal lists for Opportunistic scientists - we have details of around 3527 individuals working on Opportunistic .
This page has been viewed 308 times
Recent Search Terms used to find this page: paracoccus yeei | Scientists Urge Caution Over Claims of HIV Cure | opportunistic | most opportunistic companies | SCH-532706 | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Opportunistic across BioPortfolio, or for Opportunistic Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
